SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: notyet who wrote (27929)2/7/1999 12:13:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
APL patient population is not large, and Vessinoid (all trans retinoic acid) is approved for APL.
An MMA is the European equivalent of a US NDA (New Drug Application).